Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A MUC4	3.19e-07	4	87	3	GO:0030197
GeneOntologyMolecularFunction	extracellular matrix structural constituent	MUC17 VCAN MUC3A MUC4 MUC5AC MUC6	1.73e-04	188	87	6	GO:0005201
GeneOntologyMolecularFunction	histone H3K36 trimethyltransferase activity	SETD5 ASH1L	1.86e-04	5	87	2	GO:0140955
GeneOntologyMolecularFunction	histone modifying activity	HDAC5 SETD5 ASH1L KMT2A SRCAP KDM6A	4.96e-04	229	87	6	GO:0140993
GeneOntologyMolecularFunction	histone H3K9 monomethyltransferase activity	SETD5 ASH1L	5.17e-04	8	87	2	GO:0140948
GeneOntologyMolecularFunction	transcription coregulator activity	ZXDC MRTFB HDAC5 SETD5 MAML2 SRCAP MUC1 MED12 ZIC3	7.59e-04	562	87	9	GO:0003712
GeneOntologyMolecularFunction	histone H3K9me2 methyltransferase activity	SETD5 ASH1L	8.26e-04	10	87	2	GO:0140947
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETD5 ASH1L KMT2A	9.30e-04	44	87	3	GO:0140938
GeneOntologyMolecularFunction	minor groove of adenine-thymine-rich DNA binding	KMT2A MEF2C	1.01e-03	11	87	2	GO:0003680
GeneOntologyMolecularFunction	structural constituent of postsynaptic density	CTNND2 SHANK3	1.01e-03	11	87	2	GO:0098919
GeneOntologyMolecularFunction	tau protein binding	TTBK2 BRSK2 PICALM	1.06e-03	46	87	3	GO:0048156
GeneOntologyMolecularFunction	histone H3K9 methyltransferase activity	SETD5 ASH1L	1.42e-03	13	87	2	GO:0046974
GeneOntologyMolecularFunction	histone H3K36 methyltransferase activity	SETD5 ASH1L	1.42e-03	13	87	2	GO:0046975
GeneOntologyMolecularFunction	structural constituent of postsynaptic specialization	CTNND2 SHANK3	1.42e-03	13	87	2	GO:0098879
GeneOntologyMolecularFunction	kinesin binding	TTBK2 PLEKHM2 CLSTN2	1.78e-03	55	87	3	GO:0019894
GeneOntologyMolecularFunction	transcription coactivator activity	ZXDC MRTFB MAML2 SRCAP MED12 ZIC3	2.10e-03	303	87	6	GO:0003713
GeneOntologyCellularComponent	Golgi lumen	MUC3B MUC17 VCAN MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7 SDC1	8.75e-16	109	88	13	GO:0005796
GeneOntologyCellularComponent	postsynaptic membrane	IQSEC2 SLITRK5 GRIK1 CLSTN2 IGSF9B CSMD2 ITGB4 PICALM SHANK3	5.21e-05	405	88	9	GO:0045211
GeneOntologyCellularComponent	postsynaptic density	IQSEC2 SLITRK5 GRIK1 CLSTN2 IGSF9B CTNND2 CSMD2 PICALM SHANK3	1.18e-04	451	88	9	GO:0014069
GeneOntologyCellularComponent	synaptic membrane	CADM3 IQSEC2 SLITRK5 GRIK1 CLSTN2 IGSF9B CSMD2 ITGB4 PICALM SHANK3	1.69e-04	583	88	10	GO:0097060
GeneOntologyCellularComponent	asymmetric synapse	IQSEC2 SLITRK5 GRIK1 CLSTN2 IGSF9B CTNND2 CSMD2 PICALM SHANK3	1.80e-04	477	88	9	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	IQSEC2 SLITRK5 GRIK1 CLSTN2 IGSF9B CTNND2 CSMD2 PICALM SHANK3	2.67e-04	503	88	9	GO:0099572
GeneOntologyCellularComponent	neuron to neuron synapse	IQSEC2 SLITRK5 GRIK1 CLSTN2 IGSF9B CTNND2 CSMD2 PICALM SHANK3	3.55e-04	523	88	9	GO:0098984
GeneOntologyCellularComponent	histone deacetylase complex	HDAC5 SETD5 SRCAP SAP130	4.58e-04	85	88	4	GO:0000118
GeneOntologyCellularComponent	postsynaptic density membrane	IQSEC2 SLITRK5 GRIK1 CLSTN2 CSMD2	5.32e-04	157	88	5	GO:0098839
GeneOntologyCellularComponent	insulin-responsive compartment	PIKFYVE LNPEP	9.40e-04	11	88	2	GO:0032593
GeneOntologyCellularComponent	postsynaptic specialization membrane	IQSEC2 SLITRK5 GRIK1 CLSTN2 CSMD2	1.61e-03	201	88	5	GO:0099634
HumanPheno	Bulbous nose	SETD5 UBAP2L ASXL3 KMT2A SRCAP CPT2 SHANK3 MED12	3.83e-05	201	34	8	HP:0000414
HumanPheno	Sacral dimple	SETD5 KMT2A KDM6A SHANK3 MED12 ZIC3	7.27e-05	110	34	6	HP:0000960
HumanPheno	Sacrococcygeal pilonidal abnormality	SETD5 KMT2A KDM6A SHANK3 MED12 ZIC3	8.88e-05	114	34	6	HP:0010767
HumanPheno	Restricted or repetitive behaviors or interests	SETD5 UBAP2L ASXL3 IQSEC2 ASH1L KMT2A SRCAP SHANK3 MEF2C MED12	9.33e-05	368	34	10	HP:0031432
HumanPheno	Perseverative thought	SETD5 UBAP2L ASXL3 IQSEC2 ASH1L KMT2A SRCAP SHANK3 MEF2C MED12	1.14e-04	377	34	10	HP:0030223
HumanPheno	Skin dimple	SETD5 KMT2A KDM6A SHANK3 MED12 ZIC3	1.18e-04	120	34	6	HP:0010781
HumanPheno	Disordered formal thought process	SETD5 UBAP2L ASXL3 IQSEC2 ASH1L KMT2A SRCAP SHANK3 MEF2C MED12	1.39e-04	386	34	10	HP:0025769
Domain	SEA	MUC3B MUC17 MUC16 MUC12 MUC1 MUC3A	8.71e-10	23	88	6	PS50024
Domain	SEA_dom	MUC3B MUC17 MUC16 MUC12 MUC1 MUC3A	8.71e-10	23	88	6	IPR000082
Domain	SEA	MUC3B MUC17 MUC16 MUC1 MUC3A	4.01e-09	14	88	5	SM00200
Domain	SEA	MUC3B MUC17 MUC16 MUC12 MUC1	5.12e-08	22	88	5	PF01390
Domain	VWD	MUC5B MUC4 MUC5AC MUC6	8.02e-07	16	88	4	SM00216
Domain	VWF_type-D	MUC5B MUC4 MUC5AC MUC6	8.02e-07	16	88	4	IPR001846
Domain	VWFD	MUC5B MUC4 MUC5AC MUC6	8.02e-07	16	88	4	PS51233
Domain	VWD	MUC5B MUC4 MUC5AC MUC6	8.02e-07	16	88	4	PF00094
Domain	AT_hook	BAZ2A ASH1L KMT2A SRCAP	7.43e-06	27	88	4	SM00384
Domain	AT_hook_DNA-bd_motif	BAZ2A ASH1L KMT2A SRCAP	7.43e-06	27	88	4	IPR017956
Domain	TIL	MUC5B MUC5AC MUC6	2.16e-05	12	88	3	PF01826
Domain	C8	MUC5B MUC5AC MUC6	2.16e-05	12	88	3	PF08742
Domain	DUF3697	UBAP2 UBAP2L	2.19e-05	2	88	2	PF12478
Domain	DUF3697_Uba2	UBAP2 UBAP2L	2.19e-05	2	88	2	IPR022166
Domain	Unchr_dom_Cys-rich	MUC5B MUC5AC MUC6	2.79e-05	13	88	3	IPR014853
Domain	C8	MUC5B MUC5AC MUC6	2.79e-05	13	88	3	SM00832
Domain	TIL_dom	MUC5B MUC5AC MUC6	3.54e-05	14	88	3	IPR002919
Domain	BROMODOMAIN_2	TRIM66 BAZ2A ASH1L KMT2A	4.08e-05	41	88	4	PS50014
Domain	-	MUC17 MUC16 MUC1	4.41e-05	15	88	3	3.30.70.960
Domain	BROMO	TRIM66 BAZ2A ASH1L KMT2A	4.49e-05	42	88	4	SM00297
Domain	Bromodomain	TRIM66 BAZ2A ASH1L KMT2A	4.49e-05	42	88	4	IPR001487
Domain	-	TRIM66 BAZ2A ASH1L KMT2A	4.49e-05	42	88	4	1.20.920.10
Domain	ZF_PHD_2	TRIM66 BAZ2A ASXL3 ASH1L KMT2A	8.59e-05	95	88	5	PS50016
Domain	ZF_PHD_1	TRIM66 BAZ2A ASXL3 ASH1L KMT2A	9.03e-05	96	88	5	PS01359
Domain	VWC_out	MUC5B MUC5AC MUC6	9.27e-05	19	88	3	SM00215
Domain	HJURP_C	MEF2C MEF2D	1.31e-04	4	88	2	IPR022102
Domain	HJURP_C	MEF2C MEF2D	1.31e-04	4	88	2	PF12347
Domain	MADS_MEF2-like	MEF2C MEF2D	1.31e-04	4	88	2	IPR033896
Domain	CT	MUC5B MUC5AC MUC6	1.46e-04	22	88	3	SM00041
Domain	EGF_1	MUC3B MUC17 VCAN MUC12 MUC3A MUC4 ITGB4	2.02e-04	255	88	7	PS00022
Domain	Cys_knot_C	MUC5B MUC5AC MUC6	2.16e-04	25	88	3	IPR006207
Domain	CTCK_2	MUC5B MUC5AC MUC6	2.16e-04	25	88	3	PS01225
Domain	EGF-like_CS	MUC3B MUC17 VCAN MUC12 MUC3A MUC4 ITGB4	2.33e-04	261	88	7	IPR013032
Domain	EGF_2	MUC3B MUC17 VCAN MUC12 MUC3A MUC4 ITGB4	2.55e-04	265	88	7	PS01186
Domain	MADS	MEF2C MEF2D	3.25e-04	6	88	2	SM00432
Domain	MADS_BOX_1	MEF2C MEF2D	3.25e-04	6	88	2	PS00350
Domain	SRF-TF	MEF2C MEF2D	3.25e-04	6	88	2	PF00319
Domain	MADS_BOX_2	MEF2C MEF2D	3.25e-04	6	88	2	PS50066
Domain	WxxW_domain	MUC5B MUC5AC	3.25e-04	6	88	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	3.25e-04	6	88	2	PF13330
Domain	PHD	TRIM66 BAZ2A ASH1L KMT2A	4.33e-04	75	88	4	PF00628
Domain	TF_MADSbox	MEF2C MEF2D	4.54e-04	7	88	2	IPR002100
Domain	Znf_PHD-finger	TRIM66 BAZ2A ASH1L KMT2A	5.28e-04	79	88	4	IPR019787
Domain	Znf_FYVE_PHD	PIKFYVE TRIM66 BAZ2A ASH1L KMT2A	6.54e-04	147	88	5	IPR011011
Domain	BROMODOMAIN_1	TRIM66 BAZ2A ASH1L	6.99e-04	37	88	3	PS00633
Domain	Bromodomain	TRIM66 BAZ2A ASH1L	7.57e-04	38	88	3	PF00439
Domain	PHD	TRIM66 BAZ2A ASH1L KMT2A	8.28e-04	89	88	4	SM00249
Domain	Znf_PHD	TRIM66 BAZ2A ASH1L KMT2A	9.00e-04	91	88	4	IPR001965
Domain	SET	SETD5 ASH1L KMT2A	9.47e-04	41	88	3	PF00856
Domain	VWF_dom	MUC5B MUC5AC MUC6	1.02e-03	42	88	3	IPR001007
Domain	UBA	UBAP2 UBAP2L UBAP1	1.16e-03	44	88	3	IPR015940
Domain	SET	SETD5 ASH1L KMT2A	1.33e-03	46	88	3	SM00317
Domain	UBA	UBAP2 UBAP2L UBAP1	1.41e-03	47	88	3	PS50030
Domain	LINK	VCAN CD44	1.66e-03	13	88	2	SM00445
Domain	Link_dom	VCAN CD44	1.66e-03	13	88	2	IPR000538
Domain	Xlink	VCAN CD44	1.66e-03	13	88	2	PF00193
Domain	LINK_1	VCAN CD44	1.66e-03	13	88	2	PS01241
Domain	LINK_2	VCAN CD44	1.66e-03	13	88	2	PS50963
Domain	SET_dom	SETD5 ASH1L KMT2A	1.69e-03	50	88	3	IPR001214
Domain	SET	SETD5 ASH1L KMT2A	1.69e-03	50	88	3	PS50280
Domain	Neurexin-like	CADM3 SDC1	1.93e-03	14	88	2	IPR003585
Domain	4.1m	CADM3 SDC1	1.93e-03	14	88	2	SM00294
Domain	Glyco_hormone_CN	MUC5B MUC5AC	2.21e-03	15	88	2	IPR006208
Domain	Cys_knot	MUC5B MUC5AC	2.21e-03	15	88	2	PF00007
Domain	Post-SET_dom	ASH1L KMT2A	2.52e-03	16	88	2	IPR003616
Domain	PostSET	ASH1L KMT2A	2.52e-03	16	88	2	SM00508
Domain	AT_hook	BAZ2A KMT2A	2.52e-03	16	88	2	PF02178
Domain	POST_SET	ASH1L KMT2A	2.52e-03	16	88	2	PS50868
Domain	CTCK_1	MUC5B MUC5AC	3.20e-03	18	88	2	PS01185
Domain	UBA-like	UBAP2 UBAP2L UBAP1	3.42e-03	64	88	3	IPR009060
Domain	EGF_3	MUC3B MUC17 VCAN MUC3A MUC4	5.08e-03	235	88	5	PS50026
Domain	EGF	MUC3B MUC17 VCAN MUC3A MUC4	5.08e-03	235	88	5	SM00181
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	5.70e-20	16	73	10	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	1.38e-19	17	73	10	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	7.92e-18	23	73	10	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	3.63e-17	26	73	10	M27483
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	6.35e-13	62	73	10	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	1.68e-12	68	73	10	M27303
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC17 VCAN MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7 SDC1	8.06e-12	143	73	12	M27275
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	8.16e-12	21	73	7	MM15706
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	2.49e-10	111	73	10	M27416
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	2.46e-09	140	73	10	M27484
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC17 VCAN MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7 SDC1	5.25e-09	250	73	12	M27554
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC17 MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	2.31e-08	60	73	7	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC17 MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	1.46e-06	109	73	7	MM15164
Pathway	KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION	KMT2A KDM6A MEF2C	3.18e-04	26	73	3	M47439
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	MAGI1 INSRR SRCAP KDM6A	3.53e-04	65	73	4	M39682
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KANSL3 KMT2A KDM6A	9.87e-04	38	73	3	MM17073
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	3.07e-22	18	89	10	18834073
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC1 MUC4 MUC5AC	2.00e-10	5	89	4	11062147
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC1 MUC4 MUC5AC MUC6	2.00e-10	5	89	4	16475027
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC5B MUC5AC MUC6	5.99e-10	6	89	4	19110483
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC1 MUC4	1.62e-08	3	89	3	23053434
Pubmed	Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.	CD44 MUC16 MUC1	1.62e-08	3	89	3	12893366
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3B MUC3A MUC5AC	1.62e-08	3	89	3	18163520
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17 MUC3A	1.62e-08	3	89	3	10512748
Pubmed	A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.	MUC1 MUC5AC MUC6	1.62e-08	3	89	3	19924550
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC1 MUC4	1.62e-08	3	89	3	27483328
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC1 MUC4	1.62e-08	3	89	3	24939955
Pubmed	Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.	MUC1 MUC4 MUC6	1.62e-08	3	89	3	23446997
Pubmed	Mucin expression in reactive gastropathy: an immunohistochemical analysis.	MUC1 MUC5AC MUC6	1.62e-08	3	89	3	17227128
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC1 MUC4	1.62e-08	3	89	3	17592322
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC1 MUC4	1.62e-08	3	89	3	35879412
Pubmed	A human MAP kinase interactome.	MAGI1 POM121 RBM4B MUC12 NEB MUC1 FAM13B ITGB4 ZHX1 MEF2C MEF2D	4.86e-08	486	89	11	20936779
Pubmed	Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.	MUC5B MUC1 MUC5AC	6.47e-08	4	89	3	25638393
Pubmed	Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.	MUC5B MUC1 MUC5AC	6.47e-08	4	89	3	22269464
Pubmed	Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.	MUC1 MUC5AC MUC6	6.47e-08	4	89	3	24603585
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC5AC MUC6	6.47e-08	4	89	3	23807779
Pubmed	Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies.	MUC1 MUC4 MUC7	6.47e-08	4	89	3	21647207
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC1 MUC4	6.47e-08	4	89	3	39024979
Pubmed	Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.	MUC1 MUC5AC MUC6	6.47e-08	4	89	3	33154304
Pubmed	Gastric mucin expression in first-degree relatives of gastric cancer patients.	MUC1 MUC5AC MUC6	6.47e-08	4	89	3	24901817
Pubmed	Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).	MUC1 MUC5AC MUC6	6.47e-08	4	89	3	36367122
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC5AC MUC6	6.47e-08	4	89	3	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC5AC MUC6	6.47e-08	4	89	3	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC5AC MUC6	6.47e-08	4	89	3	29869461
Pubmed	Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?	MUC1 MUC5AC MUC6	6.47e-08	4	89	3	20929551
Pubmed	Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.	MUC5B MUC1 MUC6	6.47e-08	4	89	3	21596555
Pubmed	MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.	MUC1 MUC5AC MUC6	6.47e-08	4	89	3	27298226
Pubmed	Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon.	MUC17 MUC1 MUC4	6.47e-08	4	89	3	18198997
Pubmed	Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.	MUC1 MUC5AC MUC6	6.47e-08	4	89	3	17401217
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC5AC MUC6	6.47e-08	4	89	3	12676567
Pubmed	Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.	MUC1 MUC5AC MUC6	6.47e-08	4	89	3	25298197
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MRTFB UBAP2 POM121 HDAC5 IGSF9B MAML2 TSC22D2 SAP130 ZHX1 PICALM	1.60e-07	430	89	10	35044719
Pubmed	Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12.	MUC1 MUC5AC MUC7	1.61e-07	5	89	3	12135769
Pubmed	Differential expression of MUC genes in endometrial and cervical tissues and tumors.	MUC5B MUC1 MUC5AC	1.61e-07	5	89	3	16188033
Pubmed	Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota.	MUC17 MUC1 MUC4	1.61e-07	5	89	3	18035521
Pubmed	Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.	HDAC5 MEF2C MEF2D	3.22e-07	6	89	3	10737771
Pubmed	E-cadherin is required for intestinal morphogenesis in the mouse.	MUC17 CD44 MUC1 MUC4	4.09e-07	24	89	4	22766025
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	MAGI1 LNPEP ARHGEF12 MTCL1 PICALM PCM1	8.70e-07	125	89	6	29467281
Pubmed	Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers.	HDAC5 MEF2C MEF2D	8.99e-07	8	89	3	17786239
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MRTFB UBAP2 BAZ2A UBAP2L KMT2A SRCAP SAP130 KDM6A MED12 PCM1	1.47e-06	549	89	10	38280479
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MAGI1 RBM4B IQSEC2 ASH1L AGGF1 MTCL1 MAML2 TAF4B PICALM SHANK3 MEF2C	1.53e-06	689	89	11	36543142
Pubmed	Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.	BRSK2 MUC5B MUC5AC	2.63e-06	11	89	3	24429156
Pubmed	Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.	HDAC5 MEF2C MEF2D	5.78e-06	14	89	3	12130539
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	6.48e-06	2	89	2	7513696
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	6.48e-06	2	89	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	6.48e-06	2	89	2	14988081
Pubmed	A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.	KMT2A PICALM	6.48e-06	2	89	2	12461747
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	6.48e-06	2	89	2	15563276
Pubmed	Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival.	HDAC5 MEF2D	6.48e-06	2	89	2	12896970
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	6.48e-06	2	89	2	17621824
Pubmed	MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.	MUC4 MUC5AC	6.48e-06	2	89	2	18475301
Pubmed	Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.	MUC5B MUC7	6.48e-06	2	89	2	20946627
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	6.48e-06	2	89	2	22220206
Pubmed	Electrophoretic analysis of whole saliva and prevalence of dental caries. A study in Mexican dental students.	MUC5B MUC7	6.48e-06	2	89	2	12459324
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	6.48e-06	2	89	2	24317696
Pubmed	Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients.	MUC16 MUC1	6.48e-06	2	89	2	16194893
Pubmed	Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.	MUC1 MUC4	6.48e-06	2	89	2	28885228
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	6.48e-06	2	89	2	22391959
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	6.48e-06	2	89	2	35776514
Pubmed	Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis.	MUC1 MUC5AC	6.48e-06	2	89	2	18848467
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	6.48e-06	2	89	2	24327612
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	6.48e-06	2	89	2	28321513
Pubmed	Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours.	MUC16 MUC1	6.48e-06	2	89	2	30011875
Pubmed	Evolution of the human MUC1 oncoprotein.	MUC5B MUC1	6.48e-06	2	89	2	17671696
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	6.48e-06	2	89	2	28607090
Pubmed	IQ-ArfGEF/BRAG1 is associated with synaptic ribbons in the mouse retina.	IQSEC2 ARHGEF12	6.48e-06	2	89	2	19811534
Pubmed	Mucins 5b and 7 and secretory IgA in the oral acquired pellicle of children with caries and caries-free children.	MUC5B MUC7	6.48e-06	2	89	2	34861462
Pubmed	Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B.	MUC3B MUC3A	6.48e-06	2	89	2	10973822
Pubmed	Analysis of the discriminative methods for diagnosis of benign and malignant solitary pulmonary nodules based on serum markers.	MUC16 MUC1	6.48e-06	2	89	2	25531720
Pubmed	MUC7 Level As A New Saliva Risk Factor For Dental Caries In Adult Patients.	MUC5B MUC7	6.48e-06	2	89	2	30745804
Pubmed	Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.	MUC16 MUC1	6.48e-06	2	89	2	20598042
Pubmed	A novel mechanism in wound healing: Laminin 332 drives MMP9/14 activity by recruiting syndecan-1 and CD44.	CD44 SDC1	6.48e-06	2	89	2	32621878
Pubmed	Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.	CD44 MUC1	6.48e-06	2	89	2	18608209
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	6.48e-06	2	89	2	31030254
Pubmed	Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.	MUC16 MUC1	6.48e-06	2	89	2	27003157
Pubmed	Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency.	MEF2C MEF2D	6.48e-06	2	89	2	28738418
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	6.48e-06	2	89	2	23527003
Pubmed	Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.	MUC16 MUC1	6.48e-06	2	89	2	24039759
Pubmed	First case of B ALL with KMT2A-MAML2 rearrangement: a case report.	KMT2A MAML2	6.48e-06	2	89	2	28535805
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	6.48e-06	2	89	2	16540890
Pubmed	Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.	MUC1 MUC4	6.48e-06	2	89	2	27283771
Pubmed	Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells.	MUC1 MUC5AC	6.48e-06	2	89	2	21685325
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	6.48e-06	2	89	2	27845589
Pubmed	Quantification of MUCIN 1, cell surface associated and MUCIN16, cell surface associated proteins in tears and conjunctival epithelial cells collected from postmenopausal women.	MUC16 MUC1	6.48e-06	2	89	2	23687433
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	6.48e-06	2	89	2	27435107
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	6.48e-06	2	89	2	23544943
Pubmed	Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.	MUC1 MUC4	6.48e-06	2	89	2	19236510
Pubmed	Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.	MUC1 MUC5AC	6.48e-06	2	89	2	21815153
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	6.48e-06	2	89	2	26871672
Pubmed	KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.	KMT2A MAML2	6.48e-06	2	89	2	34550633
Pubmed	Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.	MUC5AC MUC6	6.48e-06	2	89	2	11988092
Pubmed	Glycosylation of mucins present in gastric juice: the effect of helicobacter pylori eradication treatment.	MUC1 MUC5AC	6.48e-06	2	89	2	20953890
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	6.48e-06	2	89	2	14690056
Pubmed	Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.	MUC16 MUC1	6.48e-06	2	89	2	24879526
Pubmed	UBAP2/UBAP2L regulate UV-induced ubiquitylation of RNA polymerase II and are the human orthologues of yeast Def1.	UBAP2 UBAP2L	6.48e-06	2	89	2	35633597
Pubmed	CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma.	VCAN CD44	6.48e-06	2	89	2	17957481
Interaction	MCRS1 interactions	KANSL3 EVI5 TTBK2 AGGF1 KMT2A KDM6A SHANK3 PCM1	8.03e-06	235	87	8	int:MCRS1
Interaction	CDKL5 interactions	UBAP2 UBAP2L IQSEC2 SLITRK5 CTNND2 PCM1	9.49e-06	113	87	6	int:CDKL5
Cytoband	7q22	MUC3B MUC12 MUC3A CNOT4	9.26e-07	38	89	4	7q22
Cytoband	11p15.5	BRSK2 MUC5B MUC5AC MUC6	8.55e-05	118	89	4	11p15.5
Cytoband	Ensembl 112 genes in cytogenetic band chr1q22	ASH1L MUC1 MEF2D	3.66e-04	71	89	3	chr1q22
GeneFamily	CD molecules\|Mucins	MUC3B MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7	1.26e-22	21	63	11	648
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFHX4 ZFHX2 ZHX1	1.78e-05	15	63	3	529
GeneFamily	Myocyte enhancer factor 2 proteins\|MADS box family	MEF2C MEF2D	7.14e-05	4	63	2	649
GeneFamily	Myocyte enhancer factor 2 proteins\|MADS box family	MEF2C MEF2D	1.19e-04	5	63	2	1086
GeneFamily	PHD finger proteins	TRIM66 BAZ2A ASH1L KMT2A	2.73e-04	90	63	4	88
GeneFamily	Ataxins\|Trinucleotide repeat containing	MAGI1 MED12	3.40e-03	25	63	2	775
Coexpression	NABA_ECM_AFFILIATED	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7 SDC1	1.28e-11	170	88	11	M5880
Coexpression	NABA_ECM_AFFILIATED	MUC17 MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6 SDC1	6.23e-08	158	88	8	MM17063
Coexpression	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	ARHGEF12 KMT2A MAML2 PICALM	4.42e-07	19	88	4	M13194
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	SECISBP2L CADM3 ZFHX4 ASXL3 VCAN BRSK2 SLITRK5 ARHGEF12 KIAA1549 ZFHX2 GRIK1 IGSF9B CTNND2 NEB CSMD2 SHANK3	7.51e-07	1106	88	16	M39071
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	SECISBP2L TTBK2 HDAC5 BAZ2A SETD5 DUSP5 RALGAPB UBAP1 TSC22D2 DCTN4 KDM6A MEF2D CNOT4	3.54e-06	822	88	13	M6782
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	SECISBP2L POM121 BAZ2A UBAP2L CD44 TSC22D2 DCTN4 NEDD1 SAP130 KDM6A ZHX1	1.73e-05	680	88	11	M41089
Coexpression	RICKMAN_METASTASIS_DN	UBAP2L CD44 ARHGEF12 MUC1 ITGB4 SDC1 MEF2D	3.00e-05	263	88	7	M12369
Coexpression	NABA_MATRISOME	IGSF10 MUC17 VCAN MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7 SDC1	3.71e-05	1026	88	13	M5889
Coexpression	NABA_MATRISOME_ASSOCIATED	MUC17 MUC16 MUC5B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC6 MUC7 SDC1	4.28e-05	751	88	11	M5885
Coexpression	HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL	VCAN MUC16 MUC4 ITGB4	5.70e-05	62	88	4	M45790
Coexpression	GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN	VCAN DUSP5 IQSEC2 CD44 MUC4 MUC6	5.90e-05	200	88	6	M5156
Coexpression	AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2	MAGI1 ZFHX4 VCAN CTNND2 MUC6 SDC1	9.73e-05	219	88	6	M39111
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	PIKFYVE EVI5 MAGI1 PPP4R3B MRTFB CATSPER1 RBM4B ASH1L ARHGEF12 UBAP1 DCTN4 KDM6A PICALM CNOT4	3.75e-06	780	88	14	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	MUC17 DUSP5 MUC16 MUC5B MUC3A MUC4 MUC5AC ITGB4 MGAM2	1.14e-10	184	88	9	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC ITGB4 MGAM2	2.63e-09	179	88	8	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC ITGB4 MGAM2	2.75e-09	180	88	8	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC ITGB4 MGAM2	2.75e-09	180	88	8	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC ITGB4 MGAM2	3.13e-09	183	88	8	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 MUC16 MUC1 MUC3A MUC4 ITGB4 SDC1	5.59e-08	174	88	7	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	6.53e-08	178	88	7	9a3ef66814dfca7b37024e7f79e86ea8c72ae10f
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	6.53e-08	178	88	7	b413a634283550fa224db7d0d05956e3f64694a1
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	6.53e-08	178	88	7	49a2271718637522f74334068d252963ee13b1ce
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	6.53e-08	178	88	7	19b5432aa1d7f616d58a106543c18cf2d7ca840c
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	9.84e-08	189	88	7	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	1.26e-07	196	88	7	a52879a4c822c5e4be569f01f845a795e00c5f4b
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	1.26e-07	196	88	7	7a4d502550e9e37dc42f2ff1be3c896afe365d7f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	1.26e-07	196	88	7	60ea673ed887fe3890c5cf4ff4165384b76d7361
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	1.40e-07	199	88	7	d04062d86643e5712cc2f519f4f36e643d404a16
ToppCell	Severe_COVID-19-Epithelial-Basal/Club\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	1.40e-07	199	88	7	2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	1.40e-07	199	88	7	fd364f43859b2e7a3e91ce6a1c430cc42ad26a49
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 MUC16 MUC5B MUC1 MUC4 MUC5AC	7.56e-07	159	88	6	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLEKHM2 BRSK2 TNFRSF1B ARHGAP11A NEDD1 MEF2C	1.41e-06	177	88	6	68f1139fc378f351e3b9e9f392aacb150025bf03
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	1.77e-06	184	88	6	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	COVID-19-Epithelial_cells-Tuft-like\|COVID-19 / group, cell type (main and fine annotations)	MUC5B MUC1 MUC4 MUC5AC ITGB4 SDC1	2.07e-06	189	88	6	2ffbe79fe3c3f22b1cb4269726b9eb5519be84a7
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 CEP295 MUC12 MUC1 MUC4 PCM1	2.13e-06	190	88	6	0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	2.13e-06	190	88	6	23f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 CEP295 MUC12 MUC1 MUC4 PCM1	2.13e-06	190	88	6	05455775845f4ded5c27e7b83242078d23162aaf
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	2.13e-06	190	88	6	3c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell	Enterocyte_Progenitors-C_06\|Enterocyte_Progenitors / shred on cell type and cluster	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	2.26e-06	192	88	6	b9938e1a929c00628cc6ebfdf10cf285167f445c
ToppCell	Club_cells\|World / lung cells shred on cell class, cell subclass, sample id	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.33e-06	193	88	6	9d3165dc5763a07a7d873f497624d9d6528fa2db
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 MRTFB ARHGEF12 CTNND2 SHANK3 MEF2C	2.40e-06	194	88	6	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 MRTFB ARHGEF12 CTNND2 SHANK3 MEF2C	2.40e-06	194	88	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 MRTFB ARHGEF12 CTNND2 SHANK3 MEF2C	2.40e-06	194	88	6	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4	2.55e-06	196	88	6	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.55e-06	196	88	6	a4d05d85fbafa869df19bba3881020ea433d81fb
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.55e-06	196	88	6	91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.55e-06	196	88	6	e819088a74d29e958371aa851ac9c74ec55367b7
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.55e-06	196	88	6	e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957
ToppCell	Bronchial-10x5prime-Epithelial-Epi_submucosal-gland\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLITRK5 MUC16 MUC5B NXPE2 MUC5AC MUC7	2.63e-06	197	88	6	e2c820c4e4a6cd01ceb020473286e3f5d4e3718e
ToppCell	Mild_COVID-19-Epithelial-Basal/Club\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.63e-06	197	88	6	4cc5b778e1e2c6c149160fa147c172977c0fa8eb
ToppCell	21-Trachea-Epithelial-Club-like_secretory\|Trachea / Age, Tissue, Lineage and Cell class	VCAN DUSP5 MUC16 MUC1 MUC4 SDC1	2.70e-06	198	88	6	e735d82e5151c98b5724c543f8ad633c8ed824d2
ToppCell	BL-critical-LOC-Epithelial-Secretory_LYPD2\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.70e-06	198	88	6	484d16aaa601a1e11b871b0475dd01a2de1a29ce
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SLITRK5 MUC16 MUC5B MUC1 MUC4 MUC5AC	2.70e-06	198	88	6	5dd2aa7684c36beffa204ca4c04d0501cabac10f
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.78e-06	199	88	6	70c0b9cff195d3d24e98443a729e211cac20c90f
ToppCell	5'-Adult\|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B MUC12 MUC1 MUC3A MUC4 ITGB4	2.78e-06	199	88	6	8b7b1fcea9a06522fdfab85d0dfd33010ae96d75
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.78e-06	199	88	6	a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.78e-06	199	88	6	ec1e110671e7725f752163c7241dbbf638dec2b2
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.78e-06	199	88	6	644197ff7e3299587881dd678836262e670ed4a8
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.78e-06	199	88	6	a706ad5cd5e0dc8d7e925a05e45b07d35963f294
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MRTFB ASH1L ARHGEF12 KMT2A FAM13B MEF2C	2.86e-06	200	88	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Bronchus_Control_(B.)-Epithelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	MUC16 MUC5B MUC1 MUC4 MUC5AC ITGB4	2.86e-06	200	88	6	f5bc7d30aa03dd0f95eb64255bd1a2543be8d327
ToppCell	Biopsy_IPF-Epithelial-MUC5B+\|Biopsy_IPF / Sample group, Lineage and Cell type	MUC16 MUC5B MUC1 MUC4 MUC5AC SDC1	2.86e-06	200	88	6	f0a6747f6d37ec6d261bd649ac678c39cca5e4c8
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARHGEF12 MUC16 MUC1 MUC4 ITGB4 SDC1	2.86e-06	200	88	6	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DUSP5 MUC16 MUC5B MUC1 MUC4 MUC5AC	2.86e-06	200	88	6	133853d0f55c63ebe94dd54151f9f1f90650a0d8
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DUSP5 MUC5B MUC1 MUC4 MUC5AC SDC1	2.86e-06	200	88	6	8f811ddd84c037a250d124496b0fbb2e4717011c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CATSPER1 PLEKHM2 VCAN CD44 TNFRSF1B SRCAP	2.86e-06	200	88	6	851c57187db8bc91a393655bca5f13e787a723d4
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	SETD5 ASXL3 VCAN MAML2 CSMD2	1.17e-05	149	88	5	768877bade04ca0321593b8470b5011ad8270431
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	DUSP5 MUC16 MUC5B MUC4 MUC5AC	1.86e-05	164	88	5	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MS4A18 MUC16 MUC5B MUC1 MUC5AC	2.03e-05	167	88	5	31633899aae852873a4887e72c621474b0a51a33
ToppCell	Club_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	ASXL3 DUSP5 MUC5B MUC4 MUC5AC	2.15e-05	169	88	5	03b303af8a26c6ff196507fe24f5bd3d75d7b1af
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MUC5B MTCL1 MUC5AC ITGB4 MUC6	2.34e-05	172	88	5	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MS4A18 MUC16 MUC5B MUC1 MUC5AC	2.40e-05	173	88	5	3aa1d28d4814798a772808ed29e1dbbdf92abd03
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	MUC5B MUC1 MUC4 MUC6 SDC1	2.40e-05	173	88	5	c2d973356c40e0284fd3bd7733a164b141c66008
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|367C / Donor, Lineage, Cell class and subclass (all cells)	MUC5B MUC1 MUC4 MUC6 SDC1	2.40e-05	173	88	5	d8e965ff7e9b758876ec1521c1ccedd739e8d673
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MS4A18 MUC16 MUC5B MUC1 MUC5AC	2.40e-05	173	88	5	e8afef5ae68983eb8d6515b43952636a47e9d3d4
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSRR KIAA1549 ZFHX2 IGSF9B MUC4	2.47e-05	174	88	5	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	(5)_Glands_mucous\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	SLITRK5 MUC16 MUC5B NXPE2 MUC5AC	2.75e-05	178	88	5	f0f19b0d78f2cc5df4d4c321a953a6e447d5114a
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 MUC16 MUC5B MUC4 MUC5AC	2.83e-05	179	88	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAGI1 ITGB4 CTTNBP2NL SHANK3 MEF2C	2.83e-05	179	88	5	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAGI1 MRTFB CTTNBP2NL SHANK3 MEF2C	2.83e-05	179	88	5	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	(5)_Epithelial_cells-(5)_Glands_mucous\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	SLITRK5 MUC16 MUC5B NXPE2 MUC5AC	2.90e-05	180	88	5	a4118adaf4b09e2ca01b662ed60e7bbf32a24d58
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MUC5B MUC1 MUC4 ITGB4 SDC1	3.22e-05	184	88	5	45ff845ceed5960a997545c1009012b65e377d50
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LNPEP KMT2A KDM6A MEF2C PCM1	3.22e-05	184	88	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MUC5B MUC1 MUC4 ITGB4 SDC1	3.22e-05	184	88	5	2cc2646dee3c6001f7c10b7449c17d1935021958
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DUSP5 CD44 ZFHX2 TNFRSF1B NEDD1	3.31e-05	185	88	5	48de4d9fad55077732bf64eca4919103ecbc1512
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	MAGI1 MUC16 MUC5B MUC4 SDC1	3.40e-05	186	88	5	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	MAGI1 MRTFB ITGB4 CTTNBP2NL SHANK3	3.48e-05	187	88	5	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 MUC16 MUC5B MUC1 MUC4	3.48e-05	187	88	5	71d99a1a95d3692a2891da49d4a243bae6e07fd0
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	MAGI1 CADM3 MRTFB ITGB4 SHANK3	3.57e-05	188	88	5	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC1 MUC4 MUC5AC	3.57e-05	188	88	5	5901b276f2379abf486b8285957277e95f08464e
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	MAGI1 MUC16 GRIK1 MUC1 ITGB4	3.57e-05	188	88	5	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	MUC5B MUC4 MUC5AC ITGB4 SDC1	3.66e-05	189	88	5	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	MUC16 MUC5B MUC1 MUC4 MUC5AC	3.76e-05	190	88	5	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	(7)_Epithelial-G_(Club-Clara_cells)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MUC5B MUC1 MUC4 MUC5AC SDC1	3.76e-05	190	88	5	593fd1451038b155826a48de4caa38f44406d0b9
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 MRTFB ITGB4 CTTNBP2NL SHANK3	3.85e-05	191	88	5	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 MUC16 MUC5B MUC4 MUC5AC	3.85e-05	191	88	5	529068029fb461df766135576dd0d8b5980f9bc0
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ASH1L KMT2A MAML2 KDM6A PCM1	3.95e-05	192	88	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MUC5B MUC4 MUC5AC ITGB4 SDC1	3.95e-05	192	88	5	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MUC16 MUC5B MUC4 MUC5AC ITGB4	3.95e-05	192	88	5	612be3f861bd2f71a31c57f48c8b10930c3471ea
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MUC16 MUC5B MUC4 MUC5AC ITGB4	3.95e-05	192	88	5	f627a3f43e2340c8ba502211940171f25c7ff436
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRTFB ARHGEF12 CTNND2 SHANK3 MEF2C	4.05e-05	193	88	5	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 MRTFB CTNND2 SHANK3 MEF2C	4.05e-05	193	88	5	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Club_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MUC16 MUC5B MUC1 MUC4 SDC1	4.05e-05	193	88	5	6582c0367052b9d10fb629c383ee0c55872afd2d
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 MRTFB CTNND2 SHANK3 MEF2C	4.05e-05	193	88	5	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRTFB ARHGEF12 CTNND2 SHANK3 MEF2C	4.05e-05	193	88	5	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ASXL3 MUC16 MUC5B MUC4 MUC5AC	4.15e-05	194	88	5	e0228f593c3493175962a4817500d4337ddc4e88
ToppCell	C_06\|World / shred on cell type and cluster	MUC5B MUC1 MUC4 MUC5AC MUC6	4.15e-05	194	88	5	5cb42e09f380c4468cdc603ec0c3de35eadd3213
ToppCell	cellseq-Epithelial-Epithelial_Glandular\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC4 MUC5AC MUC7	4.15e-05	194	88	5	d0fb1ff5cf0738881e114a58f0b27489f781d72b
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 MRTFB CTNND2 SHANK3 MEF2C	4.15e-05	194	88	5	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 MRTFB CTNND2 SHANK3 MEF2C	4.15e-05	194	88	5	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC3A MUC5AC MUC6 ADGRG4 MGAM2	4.25e-05	195	88	5	23ab7e2a419377c05bab0e92a2457afbcd3d9e07
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ASXL3 GAB4 MUC16 CSMD2 MUC3A	4.25e-05	195	88	5	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 CADM3 VCAN CLSTN2 ADGRG4	4.25e-05	195	88	5	f54bc4454270ff06e85596f98199372b50d0179f
Computational	Neighborhood of RBM8A	BAZ2A SETD5 RBM4B KMT2A DCTN4	7.19e-05	81	58	5	GCM_RBM8A
Drug	cellobiitol	MUC3B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC7	8.03e-11	37	86	7	CID000003871
Drug	rioprostil	MUC3B MUC12 MUC1 MUC3A MUC5AC MUC7	2.04e-09	32	86	6	CID005311413
Drug	guanidine hydrochloride	MUC3B VCAN MUC12 MUC1 MUC3A MUC4 MUC5AC MUC7	3.13e-08	129	86	8	CID000005742
Drug	Gastrin tetrapeptide	MUC3B MUC12 MUC1 MUC3A MUC5AC MUC7	3.38e-08	50	86	6	CID000005415
Drug	mucic acid	MUC3B MUC12 MUC1 MUC3A MUC5AC MUC7 MED12	4.24e-08	88	86	7	CID000000607
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A	EVI5 HDAC5 PLEKHM2 IQSEC2 AGGF1 MUC1 MUC5AC KDM6A PCM1	5.61e-08	196	86	9	3324_DN
Drug	fullerene C60	KANSL3 PIKFYVE ZXDC TTBK2 HDAC5 BAZ2A SETD5 LNPEP ASH1L ARHGEF12 GRIK1 MUC5B TAF4B SRCAP MUC4 FAM13B MUC6 MUC7 SHANK3 CNOT4	5.64e-07	1498	86	20	ctd:C069837
Drug	Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	PPP4R3B VCAN ASH1L SLITRK5 ARHGEF12 KDM6A PICALM PCM1	7.23e-07	194	86	8	4219_DN
Drug	Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	EVI5 PPP4R3B UBAP2L VCAN SLITRK5 SRCAP CPT2 MUC1	7.23e-07	194	86	8	4678_DN
Drug	inulin	MUC3B MUC12 MUC1 MUC3A MUC4 MUC5AC MUC7	7.25e-07	133	86	7	CID000024763
Drug	5186324; Up 200; 2uM; MCF7; HT_HG-U133A_EA	PPP4R3B LNPEP MTCL1 CTNND2 NEB MUC1 MUC5AC ITGB4	7.52e-07	195	86	8	900_UP
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A	SECISBP2L EVI5 LNPEP IQSEC2 SRCAP KDM6A CNOT4 PCM1	7.81e-07	196	86	8	3217_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MAGI1 ZFHX4 ARHGEF12 CLSTN2 SRCAP KDM6A MEF2D ZIC3	7.81e-07	196	86	8	4347_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MAGI1 PLEKHM2 BAZ2A ASH1L CD44 AGGF1 ITGB4 KDM6A	8.12e-07	197	86	8	4988_DN
Drug	CsCl	MUC3B CD44 GRIK1 CLSTN2 MUC3A MUC4 MUC7	8.43e-07	136	86	7	CID000024293
Drug	Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; HL60; HG-U133A	TRIM66 HDAC5 BAZ2A SRCAP PICALM MEF2C MED12 CNOT4	8.43e-07	198	86	8	1431_UP
Drug	copper(II) sulfate pentahydrate; Down 200; 100uM; PC3; HG-U133A	CADM3 HDAC5 RBM4B KMT2A MUC5AC ITGB4 CNOT4 PCM1	8.43e-07	198	86	8	459_DN
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A	KANSL3 PPP4R3B IQSEC2 ARHGEF12 TAF4B CTNND2 MEF2D CNOT4	8.43e-07	198	86	8	7373_UP
Drug	Tamoxifen citrate [54965-24-1]; Up 200; 7uM; PC3; HT_HG-U133A	HDAC5 LNPEP VCAN DUSP5 ARHGEF12 SRCAP MUC1 KDM6A	8.76e-07	199	86	8	2050_UP
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA	HDAC5 DUSP5 CD44 MUC5B SRCAP MUC5AC MEF2D	2.11e-06	156	86	7	1010_UP
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	SECISBP2L ZXDC EVI5 SLITRK5 KMT2A KDM6A CNOT4	8.32e-06	192	86	7	5058_DN
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A	HDAC5 LNPEP VCAN ASH1L SLITRK5 UBAP1 SRCAP	8.61e-06	193	86	7	5758_DN
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	SECISBP2L PPP4R3B TRIM66 TTBK2 SLITRK5 AGGF1 CNOT4	8.91e-06	194	86	7	4662_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	ZXDC PPP4R3B PLEKHM2 DUSP5 MTCL1 CPT2 MUC1	8.91e-06	194	86	7	7446_DN
Drug	Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A	CADM3 HDAC5 IQSEC2 ARHGEF12 KMT2A MEF2D PCM1	9.21e-06	195	86	7	6101_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	MAGI1 CADM3 BAZ2A CD44 KMT2A CLSTN2 SRCAP	9.21e-06	195	86	7	4345_DN
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A	PLEKHM2 DUSP5 ASH1L CD44 AGGF1 MEF2D CNOT4	9.52e-06	196	86	7	2367_DN
Drug	Nicergoline; Up 200; 8.2uM; PC3; HT_HG-U133A	TRIM66 CD44 ARHGEF12 SRCAP CPT2 KDM6A PCM1	9.52e-06	196	86	7	2058_UP
Drug	Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A	CADM3 BAZ2A IQSEC2 KMT2A MUC7 MEF2D PTH2R	9.52e-06	196	86	7	4321_UP
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	SECISBP2L ZFHX4 VCAN ARHGEF12 CPT2 MEF2C MED12	9.52e-06	196	86	7	5827_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	LNPEP SLITRK5 AGGF1 NEB SRCAP MEF2C CNOT4	9.52e-06	196	86	7	2936_DN
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	BAZ2A IQSEC2 ZFHX2 MUC5B CLSTN2 NEB SRCAP	9.52e-06	196	86	7	4419_DN
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; PC3; HT_HG-U133A	TRIM66 HDAC5 PLEKHM2 IQSEC2 ARHGEF12 TSC22D2 CNOT4	9.52e-06	196	86	7	6638_DN
Drug	Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A	KANSL3 PPP4R3B BAZ2A VCAN NEB MUC1 PCM1	9.84e-06	197	86	7	7401_UP
Drug	Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	VCAN IQSEC2 KMT2A TSC22D2 SRCAP MEF2C MEF2D	9.84e-06	197	86	7	2267_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA	CADM3 TTBK2 LNPEP IQSEC2 CD44 NEB KDM6A	9.84e-06	197	86	7	1003_UP
Drug	Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A	MAGI1 TTBK2 BAZ2A CD44 NEB MED12 PCM1	9.84e-06	197	86	7	6455_DN
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; HL60; HG-U133A	PIKFYVE BAZ2A UBAP2L KMT2A CPT2 FAM13B PCM1	9.84e-06	197	86	7	1395_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	EVI5 PLEKHM2 UBAP2L VCAN CPT2 KDM6A MEF2D	9.84e-06	197	86	7	1180_DN
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	ZXDC TTBK2 PLEKHM2 BAZ2A IQSEC2 ASH1L CNOT4	1.02e-05	198	86	7	2305_DN
Drug	Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A	BAZ2A VCAN SLITRK5 NEB SRCAP MUC1 MEF2D	1.02e-05	198	86	7	3700_DN
Drug	Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	EVI5 HDAC5 ARHGEF12 ZFHX2 TSC22D2 SRCAP CNOT4	1.02e-05	198	86	7	5731_DN
Drug	Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A	HDAC5 IQSEC2 ZFHX2 CTNND2 SRCAP ITGB4 MEF2D	1.02e-05	198	86	7	2622_UP
Drug	Enilconazole [35554-44-0]; Down 200; 13.4uM; MCF7; HT_HG-U133A	SECISBP2L PLEKHM2 CD44 ARHGEF12 DCTN4 CTNND2 SRCAP	1.05e-05	199	86	7	5538_DN
Drug	clozapine; Down 200; 10uM; MCF7; HT_HG-U133A	SECISBP2L PLEKHM2 ARHGEF12 MTCL1 SRCAP CPT2 MUC1	1.09e-05	200	86	7	6947_DN
Drug	Contact Lens Solutions	MUC16 MUC1	1.41e-05	2	86	2	ctd:D018639
Drug	heparin pentasaccharide	MUC3B MUC12 MUC1 MUC3A MUC5AC MUC7	1.79e-05	144	86	6	CID000444410
Drug	trofosfamide	VCAN MUC4 MUC5AC MUC7	3.25e-05	48	86	4	CID000065702
Drug	Boric Acids	MUC16 MUC1	4.22e-05	3	86	2	ctd:D001888
Drug	Tn epitope	MUC3B MUC3A MUC4 MUC7	5.59e-05	55	86	4	CID000447272
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	MRTFB SETD5 DUSP5 MTCL1 MEF2C CNOT4	6.25e-05	180	86	6	4541_DN
Drug	bromide	MUC3B GRIK1 MUC12 MUC1 MUC3A MUC5AC MUC7	6.88e-05	267	86	7	CID000000259
Drug	Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A	PPP4R3B VCAN SLITRK5 ARHGEF12 MUC5B PCM1	7.96e-05	188	86	6	5116_DN
Drug	thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	MAGI1 DUSP5 ARHGEF12 MUC1 MEF2D PCM1	7.96e-05	188	86	6	5921_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZXDC UBAP2L TSC22D2 TAF4B ITGB4 PCM1	8.19e-05	189	86	6	5203_DN
Drug	Chondroitin Sulfate Proteoglycans	VCAN SDC1	8.42e-05	4	86	2	ctd:D011508
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	EVI5 UBAP2L KMT2A KDM6A CNOT4 PCM1	8.43e-05	190	86	6	4322_DN
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	SECISBP2L CD44 ARHGEF12 MTCL1 NEB CNOT4	8.68e-05	191	86	6	6236_UP
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	CADM3 VCAN MUC5B SRCAP MUC1 CNOT4	8.93e-05	192	86	6	1221_UP
Drug	AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A	NEB ITGB4 KDM6A PICALM CNOT4 PCM1	9.19e-05	193	86	6	6587_UP
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A	PPP4R3B SLITRK5 ARHGEF12 ITGB4 CNOT4 PCM1	9.19e-05	193	86	6	4650_DN
Drug	5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA	HDAC5 NEB SRCAP KDM6A PCM1 ZIC3	9.46e-05	194	86	6	955_UP
Drug	(+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA	EVI5 MAGI1 ASH1L CD44 ARHGEF12 NEB	9.46e-05	194	86	6	954_UP
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CD44 TAF4B CTNND2 NEB SRCAP CNOT4	9.46e-05	194	86	6	3454_DN
Drug	Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A	VCAN SLITRK5 ARHGEF12 ITGB4 PICALM PCM1	9.46e-05	194	86	6	4602_DN
Drug	Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A	CD44 TSC22D2 MUC1 MEF2C CNOT4 ZIC3	9.73e-05	195	86	6	3423_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A	IQSEC2 AGGF1 TAF4B ITGB4 PICALM CNOT4	9.73e-05	195	86	6	3714_DN
Drug	Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	EVI5 ASH1L SLITRK5 ITGB4 MEF2D CNOT4	9.73e-05	195	86	6	6330_UP
Drug	Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PLEKHM2 BAZ2A ITGB4 MED12 CNOT4 PCM1	9.73e-05	195	86	6	7198_DN
Drug	Methyldopa (L,-) [555-30-6]; Up 200; 19uM; HL60; HG-U133A	TRIM66 BAZ2A AGGF1 SRCAP CPT2 MEF2D	9.73e-05	195	86	6	1619_UP
Drug	5151277; Up 200; 14uM; MCF7; HT_HG-U133A_EA	PPP4R3B MTCL1 NEB SRCAP CNOT4 PCM1	9.73e-05	195	86	6	903_UP
Drug	Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A	TRIM66 ZFHX4 VCAN MUC1 ITGB4 MEF2C	9.73e-05	195	86	6	4971_UP
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; PC3; HT_HG-U133A	CD44 KMT2A MUC5AC ITGB4 MEF2D ZIC3	9.73e-05	195	86	6	6691_UP
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	BAZ2A ARHGEF12 AGGF1 MUC5B MUC5AC MEF2D	9.73e-05	195	86	6	7504_UP
Drug	5286656; Up 200; 50uM; MCF7; HT_HG-U133A_EA	EVI5 PPP4R3B LNPEP VCAN CLSTN2 ZIC3	9.73e-05	195	86	6	889_UP
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A	PPP4R3B SLITRK5 NEB SRCAP MEF2D CNOT4	1.00e-04	196	86	6	2382_DN
Drug	Berberine chloride [633-65-8]; Down 200; 10.8uM; PC3; HT_HG-U133A	ZXDC TTBK2 UBAP2 HDAC5 RALGAPB CNOT4	1.00e-04	196	86	6	7143_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	VCAN SLITRK5 ZFHX2 CTNND2 MUC1 CNOT4	1.00e-04	196	86	6	3716_DN
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	EVI5 BAZ2A CD44 TSC22D2 DCTN4 PICALM	1.00e-04	196	86	6	4812_DN
Drug	Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; PC3; HT_HG-U133A	EVI5 PPP4R3B CD44 SRCAP KDM6A PCM1	1.00e-04	196	86	6	7297_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	CLSTN2 MUC4 MUC5AC MUC6 MEF2D ZIC3	1.00e-04	196	86	6	3571_UP
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A	KANSL3 CADM3 IQSEC2 ITGB4 KDM6A PCM1	1.00e-04	196	86	6	2628_UP
Drug	Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	HDAC5 ASH1L ARHGEF12 SRCAP CNOT4 PCM1	1.00e-04	196	86	6	5081_DN
Drug	Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; PC3; HT_HG-U133A	PLEKHM2 LNPEP ARHGEF12 CTNND2 ARHGAP11A MUC1	1.00e-04	196	86	6	7263_UP
Drug	Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	PPP4R3B TRIM66 BAZ2A MTCL1 CPT2 CNOT4	1.00e-04	196	86	6	7485_DN
Drug	Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A	HDAC5 BAZ2A LNPEP MTCL1 CTNND2 CNOT4	1.00e-04	196	86	6	7408_UP
Drug	Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	KANSL3 GRIK1 SRCAP MUC1 MUC5AC MEF2D	1.03e-04	197	86	6	4397_UP
Drug	Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MAGI1 ARHGEF12 UBAP1 CTNND2 PCM1 ZIC3	1.03e-04	197	86	6	2235_DN
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A	EVI5 BAZ2A IQSEC2 MUC5B TSC22D2 NEB	1.03e-04	197	86	6	4474_DN
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A	CADM3 IQSEC2 CLSTN2 SRCAP MUC1 PCM1	1.03e-04	197	86	6	3235_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	MAGI1 TTBK2 HDAC5 IQSEC2 CD44 ZIC3	1.03e-04	197	86	6	3885_DN
Drug	Tocainide hydrochloride; Down 200; 17.4uM; HL60; HT_HG-U133A	MRTFB LNPEP AGGF1 MEF2C CNOT4 PTH2R	1.03e-04	197	86	6	2931_DN
Drug	rofecoxib; Up 200; 10uM; MCF7; HG-U133A	CADM3 AGGF1 KMT2A GRIK1 TSC22D2 MEF2D	1.03e-04	197	86	6	205_UP
Drug	Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	CD44 TSC22D2 TAF4B SRCAP MUC1 PCM1	1.03e-04	197	86	6	7174_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	CADM3 IQSEC2 AGGF1 KMT2A GRIK1 MUC5B	1.03e-04	197	86	6	3639_UP
Drug	estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A	SECISBP2L EVI5 PPP4R3B MRTFB HDAC5 MEF2D	1.03e-04	197	86	6	1149_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A	PLEKHM2 BAZ2A UBAP2L VCAN UBAP1 PICALM	1.03e-04	197	86	6	2052_DN
Drug	Nizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A	EVI5 HDAC5 ARHGEF12 TSC22D2 NEB MED12	1.03e-04	197	86	6	5406_DN
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A	SECISBP2L EVI5 ZFHX2 NEB MEF2C PCM1	1.03e-04	197	86	6	2903_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	MAGI1 CADM3 ZFHX4 IQSEC2 CD44 PCM1	1.03e-04	197	86	6	7177_UP
Disease	Neurodevelopmental Disorders	SETD5 ASXL3 IQSEC2 ASH1L BRSK2 KMT2A SRCAP MEF2C	3.74e-10	93	88	8	C1535926
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC1 MUC3A MUC4 MUC5AC MUC6	8.91e-10	64	88	7	DOID:4947 (is_marker_for)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC MUC6	2.55e-07	5	88	3	DOID:3030 (is_marker_for)
Disease	Adenoid Cystic Carcinoma	MAGI1 VCAN INSRR SRCAP ITGB4 KDM6A	5.64e-07	100	88	6	C0010606
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC1 MUC3A MUC4 MUC5AC	1.10e-06	61	88	5	DOID:3587 (is_marker_for)
Disease	common bile duct neoplasm (is_marker_for)	MUC1 MUC4 MUC5AC	1.42e-06	8	88	3	DOID:4608 (is_marker_for)
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC1 MUC5AC	3.03e-06	10	88	3	DOID:10140 (is_marker_for)
Disease	pancreatic cancer (is_marker_for)	MUC16 MUC1 MUC4 MUC5AC MUC6	1.33e-05	101	88	5	DOID:1793 (is_marker_for)
Disease	otitis media (biomarker_via_orthology)	MUC1 MUC4 MUC5AC	1.69e-05	17	88	3	DOID:10754 (biomarker_via_orthology)
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	2.63e-05	3	88	2	DOID:9368 (is_marker_for)
Disease	renal cell carcinoma (is_marker_for)	LNPEP CD44 TNFRSF1B MUC1 KDM6A	4.17e-05	128	88	5	DOID:4450 (is_marker_for)
Disease	dry eye syndrome (is_implicated_in)	MUC1 MUC5AC	5.26e-05	4	88	2	DOID:10140 (is_implicated_in)
Disease	autism spectrum disorder (implicated_via_orthology)	ASH1L CTNND2 SHANK3 MEF2C MEF2D	9.43e-05	152	88	5	DOID:0060041 (implicated_via_orthology)
Disease	lung adenocarcinoma (is_marker_for)	CD44 MUC1 MUC4 SDC1	1.24e-04	85	88	4	DOID:3910 (is_marker_for)
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	1.83e-04	7	88	2	DOID:0050625 (is_marker_for)
Disease	chronic obstructive pulmonary disease (is_marker_for)	MUC5B TNFRSF1B MUC1 MUC5AC	2.07e-04	97	88	4	DOID:3083 (is_marker_for)
Disease	Cornelia De Lange Syndrome	SETD5 KMT2A	2.43e-04	8	88	2	C0270972
Disease	Anorectal Malformations	CTNND2 MED12 ZIC3	2.52e-04	41	88	3	C3495676
Disease	otitis media (is_marker_for)	MUC5B MUC4	3.90e-04	10	88	2	DOID:10754 (is_marker_for)
Disease	allergic conjunctivitis (is_marker_for)	MUC1 MUC4	3.90e-04	10	88	2	DOID:11204 (is_marker_for)
Disease	allergic rhinitis (biomarker_via_orthology)	MUC1 MUC5AC	3.90e-04	10	88	2	DOID:4481 (biomarker_via_orthology)
Disease	pulmonary fibrosis	MUC5B MUC5AC	4.75e-04	11	88	2	EFO_0009448
Disease	disks large homolog 3 measurement	MEF2C MEF2D	5.69e-04	12	88	2	EFO_0802472
Disease	plasminogen activator inhibitor 1 measurement	MUC17 UBAP1 MUC12	5.70e-04	54	88	3	EFO_0004792
Disease	schizophrenia, intelligence, self reported educational attainment	CADM3 KMT2A IGSF9B MAML2 SHANK3 CNOT4	6.02e-04	346	88	6	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	cholangiocarcinoma (biomarker_via_orthology)	MUC1 MUC4	6.71e-04	13	88	2	DOID:4947 (biomarker_via_orthology)
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	7.82e-04	14	88	2	DOID:10808 (implicated_via_orthology)
Disease	cystic fibrosis (is_marker_for)	MUC5B MUC1 MUC5AC	8.54e-04	62	88	3	DOID:1485 (is_marker_for)
Disease	number of children ever born measurement	UBAP2L MEF2C	9.00e-04	15	88	2	EFO_0009102
Disease	major depressive disorder (is_implicated_in)	CTNND2 MED12	1.16e-03	17	88	2	DOID:1470 (is_implicated_in)
Disease	prostate cancer (is_marker_for)	SETD5 KMT2A MUC1 KDM6A	1.24e-03	156	88	4	DOID:10283 (is_marker_for)
Disease	Schizophrenia	MAGI1 KMT2A GRIK1 TNFRSF1B CTNND2 CSMD2 SHANK3 MED12 PCM1	1.28e-03	883	88	9	C0036341
Disease	noggin measurement	MEF2C MEF2D	1.30e-03	18	88	2	EFO_0021995
Disease	myocardial infarction (biomarker_via_orthology)	VCAN TNFRSF1B KDM6A SDC1	1.36e-03	160	88	4	DOID:5844 (biomarker_via_orthology)
Disease	anorectal malformation	MUC5B CSMD2	1.45e-03	19	88	2	MONDO_0019938
Disease	Epilepsy, Cryptogenic	ASXL3 IQSEC2 MEF2C	1.91e-03	82	88	3	C0086237
Disease	Awakening Epilepsy	ASXL3 IQSEC2 MEF2C	1.91e-03	82	88	3	C0751111
Disease	Aura	ASXL3 IQSEC2 MEF2C	1.91e-03	82	88	3	C0236018
Disease	hemoglobin change measurement	MAGI1 KMT2A	1.95e-03	22	88	2	EFO_0600027
Disease	Sjogren's syndrome (is_marker_for)	MUC16 MUC5AC	2.33e-03	24	88	2	DOID:12894 (is_marker_for)
Disease	Parkinson disease	UBAP2 ASXL3 ASH1L IGSF9B MUC12	2.77e-03	321	88	5	MONDO_0005180

Protein segments in the cluster

Peptide	Gene	Start	Entry
TTPLTKTHSQAASLT	CTTNBP2NL	596	Q9P2B4
LTSESSIHTITPSVV	ASH1L	656	Q9NR48
SIHTITPSVVNFTSL	ASH1L	661	Q9NR48
SSKTQQPTVISHSSI	C8orf86	121	Q6ZUL3
QPTVISHSSISITFS	C8orf86	126	Q6ZUL3
STSQLSIPHTSRSLI	CATSPER1	321	Q8NEC5
SELPSSLLSTSHETT	CSMD2	2041	Q7Z408
LSTSLSEPIHVTESS	VCAN	726	P13611
DTQTSPSTVPTSVHI	VCAN	1966	P13611
ASSTHVISTTSTPEA	ADGRG4	1156	Q8IZF6
ISTHPEASSRTTITA	ADGRG4	2101	Q8IZF6
TQSHSSLLSSSVLTP	BAZ2A	1276	Q9UIF9
QTHPTNSTSGTTLST	GRIK1	881	P39086
TIESPLHENISNSTS	AGGF1	341	Q8N302
VTSTPHELSISISNV	CADM3	86	Q8N126
SSIQHSSVVPSIATV	CLSTN2	821	Q9H4D0
TVQSTISSSPIHQLS	CTNND2	336	Q9UQB3
DHSTTLTSSLSLTVS	ASXL3	1476	Q9C0F0
TLISSKPQSHSLSTS	ARHGEF12	1186	Q9NZN5
QINHNVLSTSTLSSP	CPT2	581	P23786
SSTPETAHTSTVLTA	MUC5B	2011	Q9HC84
PGTTHTATVLTTTTT	MUC5B	2096	Q9HC84
SIPGTTHTATVLTTT	MUC5B	3351	Q9HC84
AATTSTTQHSTPALS	MUC5B	3496	Q9HC84
STPETAHTSTVLTTT	MUC5B	3826	Q9HC84
SSTPETTHTSTVLTT	MUC5B	4781	Q9HC84
STTTRESPVHTTIND	MTCL1	1746	Q9Y4B5
TTVHTTPILTESSLF	KIAA1549	791	Q9HCM3
HSASSKLTSPVVTTS	MUC16	3971	Q8WXI7
TSISSPHQFITSTNT	MUC16	4351	Q8WXI7
AATTDIETTHPSINT	MUC16	4816	Q8WXI7
VTSTLQEHSTSSLVS	MUC16	6236	Q8WXI7
QEHSTSSLVSVTSVP	MUC16	6241	Q8WXI7
HPSTSTAATNVETTS	MUC16	6881	Q8WXI7
FTLDTSTTPSLVITH	MUC16	7341	Q8WXI7
QPSTHTAVTNVRTSI	MUC16	8346	Q8WXI7
ITYSETHTSSAIPTL	MUC16	11436	Q8WXI7
TSQQITTAPSTNHST	MUC4	606	Q99102
SITSTGLTSPQTETH	MUC4	941	Q99102
HATSLPVTDTSSVST	MUC4	1101	Q99102
SSVSTDHATSLPVTI	MUC4	1431	Q99102
LPVTDTSSVSTAHAT	MUC4	1761	Q99102
DTTPLHVTDASSVST	MUC4	1901	Q99102
VTSTSTTSITPNHTS	MUC6	1761	Q6W4X9
TTSITPNHTSTGTRT	MUC6	1766	Q6W4X9
ITTTHTPSQQGTQET	MAGI1	1111	Q96QZ7
TSSTSVLHSSPLNVF	NEDD1	451	Q8NHV4
ITATSHTSTDDTVPN	MGAM2	2161	Q2M2H8
THTLTSIPSSITSIL	MGAM2	2301	Q2M2H8
TTHISVSNLTTASVT	MGAM2	2431	Q2M2H8
LNTTTPDSTVHTSAT	MGAM2	2486	Q2M2H8
HSTSTSTSPATTLQR	IQSEC2	221	Q5JU85
SNSVTATSTHISPIS	FAM13B	276	Q9NYF5
TTTNSVTSLNSPHSG	KDM6A	836	O15550
TSSNHSTSPQLSTGV	MUC1	1026	P15941
SIPSLSHSVISQTSF	BRSK2	556	Q8IWQ3
AVTSTPTVNQHETST	PCM1	791	Q15154
ITISHPTSICVTTTQ	MUC3A	136	Q02505
NLVTTTTEISSHSTP	MUC3A	386	Q02505
PASTSTLHTTAESTL	MUC3A	556	Q02505
TLHTTAESTLAPTTT	MUC3A	561	Q02505
TSHTTNTTPLSTLVT	MUC3A	1056	Q02505
TETISSLPASTNTIH	MUC3A	1301	Q02505
SLPASTNTIHTTAES	MUC3A	1306	Q02505
VPSTEVTTSHTTNTN	MUC3A	1426	Q02505
VTTSHTTNTNPVSTL	MUC3A	1431	Q02505
PTTNLVTTTTKTTSH	MUC3A	1511	Q02505
NLVTTTTKITSHSTP	MUC3A	1891	Q02505
HSTPRFTSSITNTKT	MUC3A	1936	Q02505
SITTTETTSHNTPSL	MUC3A	1961	Q02505
ETTSHNTPSLTSSIT	MUC3A	1966	Q02505
SSITTTETTSHNTPS	MUC3A	2011	Q02505
TETTSHNTPSLTSSI	MUC3A	2016	Q02505
HNTPSLTSSITTTET	MUC3A	2021	Q02505
TTSHSTPSFTSLITI	MUC3A	2051	Q02505
TETTSHSTPSFTSLI	MUC3A	2151	Q02505
HSTPSFTSLITTTET	MUC3A	2156	Q02505
PSFTSSNTITETTSH	MUC3A	2186	Q02505
TSLITTTKTTSHSTP	MUC3A	2291	Q02505
TTSHITPGLTSSITT	MUC3A	2401	Q02505
TRTHIISSSPSIQST	MUC3A	2521	Q02505
SSTSTLHTLTPSTAL	MUC3A	2606	Q02505
STIVSTSQVPIPSTH	MUC3A	2621	Q02505
SASITPVFSTTIHSV	MUC3A	2696	Q02505
ASQVASPSTSLHTTS	EVI5	46	O60447
LHTTSSSTTLSTPAL	EVI5	56	O60447
TVALPVTTLHNTVTS	MRTFB	451	Q9ULH7
VTTLHNTVTSSVSTL	MRTFB	456	Q9ULH7
SSHPISSSVQSSEQI	LNPEP	526	Q9UIQ6
SSHVISAQSTSTLPT	MED12	316	Q93074
STHLSQSSNLSLPST	MEF2C	371	Q06413
TATSVTQGTHTTLVT	MUC5AC	1726	P98088
TSVTQGTHTTPVTRN	MUC5AC	2101	P98088
TTPVSKTSTSHLSVS	MUC5AC	4601	P98088
SHSTPSSSISQDNIV	PPP4R3B	511	Q5MIZ7
LPQVQSTTVTSHLNS	RBM4B	251	Q9BQ04
STTVTSHLNSTSVDP	RBM4B	256	Q9BQ04
SSITTTHTSATEPFL	ITGB4	1761	P16144
VSTHTILTPNSSLLS	MAML2	836	Q8IZL2
PTTTTVTTFSQSLHT	POM121	891	Q96HA1
QSLHTAVPTATSSSA	POM121	901	Q96HA1
DTSETSAAPTHQTTT	MUC7	321	Q8TAX7
SAAPTHQTTTSVTTQ	MUC7	326	Q8TAX7
SSQSSTSSTHLQLPT	PIKFYVE	1566	Q9Y2I7
SHTTQILSTSTFPSD	IGSF10	971	Q6WRI0
QIPSNTLTTAHHTTT	IGSF10	1261	Q6WRI0
HPTTSTLTSSNRNDV	CD44	526	P16070
SSSQHPISTQSITNT	GAB4	466	Q2WGN9
TIHPVNTTTSPVNTT	MS4A18	331	Q3C1V0
TVPQDVISTSNSSSH	INSRR	606	P14616
VSSSTAPSALHTLQS	KANSL3	716	Q9P2N6
TSTISQDTSHLTSGS	KMT2A	3316	Q03164
TVTNSHLTASPKLST	HDAC5	381	Q9UQL6
LVSSSSSPVVVQHSV	CEP295	1096	Q9C0D2
HTLSTRATSISTQLP	DCTN4	81	Q9UJW0
THSTVSELSRSPVAT	DUSP5	366	Q16690
SQSTHSLTTPVVSVA	MEF2D	301	Q14814
SSSDTTPVHTTSQEK	PLEKHM2	281	Q8IWE5
TLSTTPLDTSTHITT	MUC17	766	Q685J3
PLDTSTHITTSTEAS	MUC17	771	Q685J3
STPAPNTEVITSHTT	MUC3B	296	Q9H195
IHSTVSSSTTAITSP	MUC3B	361	Q9H195
IHIISSSPSIQSTET	MUC3B	436	Q9H195
STSTLHTLTPSTALS	MUC3B	521	Q9H195
KQVTTISHSSTLTIQ	TAF4B	541	Q92750
NSSSTPVSVHIDTSS	ARHGAP11A	361	Q6P4F7
LSSHTPVSRSSSIIQ	TSC22D2	541	O75157
TTSATHSTATILNPQ	NXPE2	106	Q96DL1
STVLYTATQHTPTSI	SETD5	146	Q9C0A6
TATQHTPTSITLTVR	SETD5	151	Q9C0A6
RETTQLPTTHLASTT	SDC1	126	P18827
LPTTHLASTTTATTA	SDC1	131	P18827
LLNSSITSTTSTLVP	SECISBP2L	971	Q93073
ISQHQISTSIITSTQ	MT-ND5	566	P03915
HTPVISAHQTRSTTT	SRCAP	2411	Q6ZRS2
SPSESSSSITSENVH	SLC36A3	21	Q495N2
LSPTSLQNSSSHTTT	CNOT4	431	O95628
ISSDVSTFTTRTPTH	PICALM	451	Q13492
TTKTPSAVQTSTSHN	ZIC3	441	O60481
TPSTQQNSTSHPTTT	UBAP2	391	Q5T6F2
VNTPITSVSLSHSSS	ZFHX4	416	Q86UP3
SNLAAHITTPTSSST	ZXDC	631	Q2QGD7
HNSILTPTRVSSSAT	UBAP1	126	Q9NZ09
HSEEIPNTTTTQHSS	UBAP2L	681	Q14157
PNTTTTQHSSTLSTQ	UBAP2L	686	Q14157
HTDSNPKTTTTSTLL	ZFHX2	2556	Q9C0A1
SDPHLETTSTISTVS	SHANK3	1366	Q9BYB0
LHTTPASVNSVATSS	SLITRK5	306	O94991
TNVVTSITASTHLTV	IGSF9B	491	Q9UPX0
GSVSHTQAPTSTIVT	SAP130	396	Q9H0E3
LTTTTTSTTPQLHTR	TTBK2	306	Q6IQ55
TSIVNRIHPSTASTV	ZHX1	236	Q9UKY1
ASKVQHQTSSTSPLS	RALGAPB	406	Q86X10
VLTTVTHSTSSQSQV	PTH2R	451	P49190
QQHLLITAPSSSSSS	TNFRSF1B	316	P20333
TTSHLQTVPSLVHST	TRIM66	696	O15016
HTISSAPSTTSALVE	MUC12	866	Q9UKN1
STTTSDLSQEPTTSH	MUC12	1486	Q9UKN1
HTISSAPSTTSALVE	MUC12	3506	Q9UKN1
TQQTTVSSIPSHPST	NEB	6596	P20929